Kidney Diseases clinical trials

Explore recruiting kidney diseases clinical trials.

Recruiting kidney diseases studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Kidney Diseases trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 2, Open-Label, Single-Arm, Cohort Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Sparsentan Treatment in Pediatric Subjects with Selected Proteinuric Glomerular Diseases (EPPIK)

Poland, Germany, Sweden, Netherlands, Italy, Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

An Open-label, Single Arm Study to Evaluate the Safety and Tolerability of Intravenous Difelikefalin in Adolescents Aged 12 to 17 Years on Haemodialysis with Moderate-to-Severe Pruritus (KOR-PED-202)

Spain, Greece, Italy, Portugal

Therapeutic exploratory (Phase II) EU CTIS Study details

PODOMOUNT-Basket, a Phase II, multicentre, randomised, 2-arm parallel-group, double-blind, placebo-controlled basket trial to assess safety, tolerability, PK, and efficacy of BI 764198 in four proteinuric kidney diseases

Portugal, Greece, Italy, Poland, Estonia, Slovakia +10 more

Therapeutic exploratory (Phase II) EU CTIS Study details

Study to look at the safety, tolerability, and how the body processes the study medicine WAL0623 after single or repeated doses, with or without food, in healthy volunteers

Italy

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

Real-World Effectiveness and Safety of Pegcetacoplan in Patients with C3 Glomerulopathy (C3G) or Primary Immune Complex Membranoproliferative Glomerulonephritis (IC-MPGN): A Multi-Country Study (PRISMC3)

France, Italy, Spain, Germany

Therapeutic use (Phase IV) EU CTIS Study details

Kidney Diseases trials by city

Kidney Diseases in Toronto Kidney Diseases in Vancouver Kidney Diseases in Montreal Kidney Diseases in Calgary Kidney Diseases in Edmonton Kidney Diseases in Ottawa Kidney Diseases in Winnipeg Kidney Diseases in Quebec City Kidney Diseases in Hamilton Kidney Diseases in Kitchener Kidney Diseases in London Kidney Diseases in Halifax Kidney Diseases in New York Kidney Diseases in Los Angeles Kidney Diseases in Chicago Kidney Diseases in Houston

Kidney Diseases clinical trials

Recruiting kidney diseases studies right now

Patiromer and Diet/hrQoL in Chronic Dialysis

A Clinical Trial to Test the Safety, Tolerability, and How the Body Processes CPV-104 in Healthy People and Patients With C3-Glomerulopathy

A Study Comparing the Necessity of a Second Transurethral Resection in High-Risk Non-Muscle-Invasive Bladder Cancer Patients With Negative Results From Post-Initial Resection Urine Genome-Wide Low-Depth Sequencing

A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and Proteinuria

Effects of Variation of Sodium Dialysate in ICU

Impact of Surgical Position on Stone-Free Rates in Retrograde Intrarenal Surgery

Bendable Suction Ureteral Access Sheath Versus Conventional Ureteral Access Sheath in Management of Renal Stones Using Flexible Ureteroscopy

Probiotic Supplementation and Disease Progression in CKD: A Randomized Trial

A Study to Investigate IGT-303 in Healthy Volunteers and Participants With Chronic Kidney Disease

The Choice of Vasopressor to Prevent Postoperative Acute Kidney Injury After Major Non-Cardiac Surgery

A Study of Telitacicept in Lupus Nephritis

Prospective Study on the Safety and Efficacy of Robot-Assisted Laparoscopic Partial Nephrectomy With Renal Artery Off-Clamp in the Treatment of cT1 Renal Tumors

Also recruiting in Europe

A Phase 2, Open-Label, Single-Arm, Cohort Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Sparsentan Treatment in Pediatric Subjects with Selected Proteinuric Glomerular Diseases (EPPIK)

An Open-label, Single Arm Study to Evaluate the Safety and Tolerability of Intravenous Difelikefalin in Adolescents Aged 12 to 17 Years on Haemodialysis with Moderate-to-Severe Pruritus (KOR-PED-202)

PODOMOUNT-Basket, a Phase II, multicentre, randomised, 2-arm parallel-group, double-blind, placebo-controlled basket trial to assess safety, tolerability, PK, and efficacy of BI 764198 in four proteinuric kidney diseases

Study to look at the safety, tolerability, and how the body processes the study medicine WAL0623 after single or repeated doses, with or without food, in healthy volunteers

Real-World Effectiveness and Safety of Pegcetacoplan in Patients with C3 Glomerulopathy (C3G) or Primary Immune Complex Membranoproliferative Glomerulonephritis (IC-MPGN): A Multi-Country Study (PRISMC3)

Kidney Diseases trials by city

Other conditions